The long-term objectives of this project are to determine the mechanisms by which erythropoietin (EPO) contributes to the control of the proliferation and differentiation of erythrocytes. Our efforts have focused on the identification of the biochemical consequence of Epo receptor activation and assessing the role of these responses in the various cellular responses including promoting cell cycle progression, suppression of apoptosis and differentiation. We have demonstrated that Epo induce the activation of a variety of signaling pathways, including the activation of the transcription factors Stat5a and Stat5b, but that these functions are dispensable including the activation of the transcription factors Stat5a and Stat5b, but these functions are dispensable based on studies with receptor mutants. To extend these observations, the first specific aim will assess the requirement for these functions in the broadest physiological terms in erythropoiesis. This will be accomplished by deriving mice that express various Epo receptor mutants that have lost the ability to activate various pathways. These mutant strains will be further used to determine whether the distal region of the Epo receptor mediates functions that are redundant to the minimally essential, membrane proximal region of the receptor. One of the critical functions mediated by Epo receptor activation of Jak2 is the induction of genes that are required for the expression of Bcl-X/L as well as other genes. In the second specific aim we proposed to focus on the identification and characterization of a specific group of immediately early genes in the Epo response. For these studies. mutants will be used that contain the minimal receptor required for function. Differential expression, cloning approaches will be used to identify the genes induced. Two genes have been identified in preliminary studies and their function, as well as genes to be identified, will be assessed for function by deriving strains of mice that lack the genes. Together the studies will provide new insights into the critical biochemical functions that are induced by Epo that are essential for hematopoiesis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL053749-08
Application #
6501105
Study Section
Project Start
2001-09-01
Project End
2002-08-31
Budget Start
Budget End
Support Year
8
Fiscal Year
2001
Total Cost
$126,320
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Zhao, Hui Fen; Abraham, Allistair; Kim, Yoon-Sang et al. (2017) Lentiviral Transfer of ?-Globin with Fusion Gene NUP98-HOXA10HD Expands Hematopoietic Stem Cells and Ameliorates Murine ?-Thalassemia. Mol Ther 25:593-605
De Ravin, Suk See; Wu, Xiaolin; Moir, Susan et al. (2016) Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency. Sci Transl Med 8:335ra57
Abraham, Allistair; Kim, Yoon-Sang; Zhao, Huifen et al. (2016) Increased Engraftment of Human Short Term Repopulating Hematopoietic Cells in NOD/SCID/IL2r?null Mice by Lentiviral Expression of NUP98-HOXA10HD. PLoS One 11:e0147059
Wielgosz, Matthew M; Kim, Yoon-Sang; Carney, Gael G et al. (2015) Generation of a lentiviral vector producer cell clone for human Wiskott-Aldrich syndrome gene therapy. Mol Ther Methods Clin Dev 2:14063
Pestina, Tamara I; Hargrove, Phillip W; Zhao, Huifen et al. (2015) Amelioration of murine sickle cell disease by nonablative conditioning and ?-globin gene-corrected bone marrow cells. Mol Ther Methods Clin Dev 2:15045
Zhou, Sheng; Bonner, Melissa A; Wang, Yong-Dong et al. (2015) Quantitative shearing linear amplification polymerase chain reaction: an improved method for quantifying lentiviral vector insertion sites in transplanted hematopoietic cell systems. Hum Gene Ther Methods 26:4-12
Urbinati, Fabrizia; Hargrove, Phillip W; Geiger, Sabine et al. (2015) Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells. Exp Hematol 43:346-351
Treanor, Louise M; Zhou, Sheng; Janke, Laura et al. (2014) Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential. J Exp Med 211:701-13
Griffith, Linda M; Cowan, Morton J; Notarangelo, Luigi D et al. (2014) Primary Immune Deficiency Treatment Consortium (PIDTC) report. J Allergy Clin Immunol 133:335-47
De Ravin, Suk See; Gray, John T; Throm, Robert E et al. (2014) False-positive HIV PCR test following ex vivo lentiviral gene transfer treatment of X-linked severe combined immunodeficiency vector. Mol Ther 22:244-245

Showing the most recent 10 out of 152 publications